Age differences in depression, anxiety, and cognitive dysfunction among people with multiple sclerosis
Description: Multiple sclerosis (MS) is an inflammatory neurological condition that affects approximately 1 in 400 Canadians and causes a diverse range of symptoms. Often under-recognized and insufficiently addressed, between 40-90% of people with MS have cognitive impairment, with most studies describing a higher prevalence in older adults. Cognitive dysfunction can lead to social isolation, unemployment, and worsened quality of life. It is thus vital to identify causes of cognitive impairment, particularly for older adults with MS. Depression and anxiety - both common in MS - may be two treatable contributors to cognitive dysfunction. In prior research, we identified that depression, especially with anxiety, is an independent predictor of cognitive impairment among people with MS. However, it remains unclear whether the relationships between depression, anxiety, and cognition differ depending on the age of the person with MS. This is particularly important because with the use of disease-modifying therapies, people with MS are aging; and yet, much less research is conducted involving older adults with MS. In my proposed research, I aim to evaluate whether there are age differences in how depression and anxiety influence cognition in people with MS. In routine clinical care, over 800 people with MS who attended a Canadian neuropsychiatry clinic completed validated scales to assess depression and anxiety, and engaged in comprehensive cognitive testing. This data will be used for the statistical analyses in this research project. It is currently unknown whether treating depression and anxiety would improve cognition for older adults with MS. I hope that the findings from my study will support investigations to answer this question, enhancing the quality of care for people with MS.
Amount: CA$27,000
Funding type: fellowship
Funder scheme: Master's Award: Canada Graduate Scholarships
Start date: 2024-09-01
End date: 2025-08-31
Investigator: David Freedman (lead)
Institution: University of Toronto
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: 194341_1
OpenAlex ID: G4612533534
